Glonghui on December 6 | Goldenrabi (002762.SZ) announced that on December 6, 2023, the company received a notice from the Guangdong Drug Administration on its official website agreeing to resume production by our cosmetics factory (No. 93 of 2023): According to Section 60 of the “Regulations on the Supervision and Administration of Cosmetics” and Article 59 of the “Measures for the Supervision and Administration of Cosmetics Production and Operation”, the Guangdong Drug Administration organized an on-site rectification of the cosmetics factory under the Babylabi brand The inspection also stated, “The enterprise has completed the rectification of the defective project as required, and has now agreed with the above company to resume production.”
Blonde rabbi (002762.SZ): Cosmetics factories under the Baby Rabbi brand resume production and operation
Gelonghui Finance · 12/06/2023 16:32
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.